top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato A4GALT
alpha-galactosidase A
animal models
astrogliosis
autophagy
axon guidance
biomarkers
bone involvement
cathepsin D
chloroquine
clathrin
Dkk1
dried blood spot
endocytic pathways
endocytosis
enzyme replacement therapy
exosomes
experimental therapies
Fabry disease
GAA biomarker
Gaucher disease
Gaucher Disease
gene therapy
GLA gene
globotriaosyl-sphingosine (lysoGb3)
globotriaosylceramide (Gb3)
globotriaosylsphingosine
glycogen
hematopoietic stem cell transplantations
Hurler syndrome
IGF2R/M6P
iPSC
Krabbe disease
lyso-Gb3
lysosomal diseases
lysosomal storage disorder
lysosomal storage disorders
lysosomal targeting
lysosomal α-glucosidase
lysosome
lysosomes
MIP-1β
mucolipidosis II
mucopolysaccharidosis IIIB
mucopolysaccharidosis type I
muscle
NAGLU
neurodegenerative disease
neuronal circuit
neuronopathy
newborn screening
Osteoimmunology
Osteopontin
Parkinson disease
pharmacological chaperone therapy
pharmacological chaperones
Pompe disease
precision medicine
psychosine
quantitative proteomics
RANK/RANKL
rhGAA
satellite cells
second tier test
sortilin
substrate reduction therapy
tandem mass spectrometry
TGF-beta
Twitcher mouse
variant interpretation
viral vectors
visual cortex
visual system
Wnt/β-catenin
Wnt3a
α-galactosidase A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui